According to an article published by the Journal of the American Medicine Association (JAMA) Neurology, treating symptomatic intracerebral haemorrhage (sICH) after clot-busting thrombolysis for stroke was not associated with a reduced likelihood of in-hospital death or expansion of the haematoma. Shortening time to diagnosis and treatment, however, may be key to improving outcomes.
Patients with high baseline diastolic blood pressure undergoing carotid endarterectomy are at increased risk of stroke, myocardial infarction, or death within 30 days of the procedure, according to results from the International Carotid Stenting Study (ICSS). In a paper published in the European Journal of Vascular and Endovascular Surgery, the authors say that in the context of a single preoperative measurement of blood pressure, diastolic blood pressure might be a better predictor than systolic blood pressure.
James Bond´s nemesis in the most recent film likely failed neuroanatomy, said real-life neurosurgeon and scientist Dr. Michael Cusimano of St. Michael´s Hospital.
The out-of-hospital birth setting in Oregon was associated with a higher risk of perinatal death, while the in-hospital birth setting was associated with a higher risk for cesarean delivery and other obstetric interventions (e.g., induction or augmentation of labor), according a study published today in the New England Journal of Medicine by researchers at Oregon Health & Science University.
Using mice whose front paws were still partly disabled after an initial induced stroke, Johns Hopkins researchers report that inducing a second stroke nearby in their brains let them “rehab” the animals to successfully grab food pellets with those paws at pre-stroke efficiency.
New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA™, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients. DURLAZA is now commercially available for physicians and their patients
Scientists at VIB and KU Leuven have identified the oxygen sensor PHD1 as a potential target for the treatment of brain infarction (ischemic stroke). Despite (minor) improvements in stroke treatment, stroke remains the fourth leading cause of death and the most common reason of severe disability. The impact of stroke is overwhelming for the patient, family and society -representing one of the largest unmet medical needs. Research led by prof. Peter Carmeliet and dr. Annelies Quaegebeur (VIB/KU Leuven) indicates that inhibition of PHD1 offers protection against stroke, via an unexpected mechanism, raising hope for future stroke treatment. The study was published in the leading medical journal Cell Metabolism.
A UT Southwestern Medical Center study to evaluate nursing protocols designed to better triage and treat stroke patients using telemedicine will be the first study using a new consortium of medical centers.
Researchers stress the need for early occlusion of subarachnoid aneurysms to prevent death from rebleeding.
Researchers at the University of Arizona have invented a device that for the first time allows neurosurgeons, who use microscopes extensively while operating, to see blood flowing inside vessels and more clearly distinguish cancerous from healthy tissue under the microscope.
People with diabetes may be harboring advanced vascular disease that could increase their risk of stroke, according to new research being presented next week at the annual meeting of the Radiological Society of North America (RSNA). The findings suggest that arterial imaging with 3-D MRI could be useful in helping to determine stroke risk among diabetics.
The first US commercial case using Silk Road Medical’s Enroute transcarotid stent system has been successfully performed at Kaiser Permanente Moanalua Medical Center in Honolulu, Hawaii, by vascular surgeon Peter A Schneider. The Enroute transcarotid stent is designed specifically for transcarotid artery revascularisation (TCAR), combining the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.
Medtronic plc has announced the first implants of the TYRX Absorbable Antibacterial Envelope with Medtronic deep brain stimulation (DBS) systems. The implants were conducted by Francisco Ponce, director, Barrow Center for Neuromodulation, at the Barrow Neurological Institute in Phoenix, USA. Medtronic recently received FDA clearance for the TYRX Neuro Absorbable Antibacterial Envelope for use with implantable neurostimulators, and the product is now commercially available across the United States as an option for use with all DBS systems. In the coming months, Medtronic also plans to make the TYRX Absorbable Antibacterial Envelope available as an option for use with implantable neurostimulators to treat chronic pain and bladder and bowel control disorders.
Novel brain-computer interface technology created by University of California, Irvine researchers has allowed a paraplegic man to walk for a short distance.
Researchers published results of a novel study of the functional activation patterns of working memory after mild traumatic brain injury (TBI). This study, the first to enrol subjects during their initial evaluation in the emergency room, provides new information on the acute effects of TBI on cognition. The fMRI studies, conducted at <72 hours after injury and at one week after TBI, provide neuroimaging evidence for working memory deficits during the week following injury.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos